Plain-English translation of NCT05032053 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After a stroke, doctors typically prescribe (blood clot prevention medications) to help prevent another stroke. However, some patients have small bleeding spots in their brains called cerebral microbleeds, and these medications may increase the risk of bleeding in people with this condition. This study will follow 3,000 stroke patients with microbleeds to see how safe and effective different blood clot prevention approaches are for them over one year.
Doctors face a difficult choice when treating stroke patients who have cerebral microbleeds: the medication needed to prevent future strokes might increase the risk of brain bleeding. This trial exists to figure out the safest and most effective way to protect these patients from another stroke without causing harm.
You likely qualify if…
You likely don't qualify if…
You will be enrolled in a registry where researchers track how you recover over one year while taking your prescribed blood clot prevention medication. You'll have follow-up visits where doctors will monitor your progress and any new symptoms. The study will also collect a small blood sample from you to test for protein markers that might help predict how well the medication works for patients with microbleeds.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China